Music & Memory Research Study
The Impact of Music Brain Stimulation in Adults with Memory Loss
Boston, MA
Compensation Provided
Normal Hearing
With Memory Loss
50 Years and Older
Fast Facts
About this research study:
At the Music, Imaging, and Neural Dynamics Laboratory (MIND) at Northeastern University, we are investigating the effects of music and multisensory stimulation on brain activity in adults who are experiencing memory loss.
The MIND Lab is seeking older adults with Mild Cognitive Impairment (MCI) or those who may be experiencing Subjective Cognitive Decline (SCD) to participate in a research study on how music listening affects brain activity and gene expression. We will record the participant's brain activity using a safe, non-invasive procedure called EEG (electroencephalography) as they listen to recorded music via headphones and watch lighting effects that synchronize to the beat of the music.
Additional Information
What is the purpose of our research?
At the Music, Imaging, and Neural Dynamics Laboratory at Northeastern University, we are investigating the effects of music and multisensory stimulation on brain activity in adults who are experiencing memory loss. We will record participant's brain activity using a safe, non-invasive procedure called EEG (electroencephalography) as they listen to recorded music via headphones and watch lighting effects that synchronize to the beat of the music.
Do I qualify for this study?
You must be 1) aged 50+, and 2) have normal hearing.

You will be included if you meet the following criteria:
Adults at least 50 years old with (a) MCI or (b) SCD, defined as:

A. Mild Cognitive Impairment (MCI): Physician confirmed diagnosis of MCI at least 6
weeks ago and current exam within the past 12 months; or

B.
Subjective Cognitive Decline (SCD): presence of subjective cognitive deficits within
the past 6 months.

You will be excluded from participation if you meet the following criteria:
1. Recently (within the last 6 weeks) changed dosage of cholinesterase inhibitors (e.g.,
donepezil (Aricept), galantamine (Razadyne), rivastigmine (Exelon)) or psychotropic
medication (e.g., anti-psychotics, tricyclics, SSRIs, MAOIs, anti-panic or anti-anxiety
agents)
2. History of psychotic or schizophrenic episodes, major neurologic diagnosis
(Parkinson's, stroke, brain injury, epilepsy) or other condition that might impair cognition
or confound assessments (e.g., cardiovascular event within the past 6 months
(myocardial infarction, unstable angina, hospitalization for congestive heart failure,
bypass surgery or angioplasty (coronary or carotid), TIA)
3. History of chemotherapy treatment within the past 10 years
4. Recent (within the last 3 months) serious physical trauma or diagnosis of serious
chronic health condition requiring medical treatment and monitoring (e.g., uncontrolled
hypertension, serious endocrine or pulmonary disorder, renal disease, active cancer
treatment)
5. Participant in another intervention study within the past 30 days
    Is there compensation provided to study participants?
    Compensation is $20/hour upon completion of the study.
    This study is approved by the Northeastern IRB (#19-03-20).